Caprolactam Chemicals Limited Caprolactam Chemicals reported a standalone net loss of ₹98.86 lakh for the quarter ended June 30, 2026, compared to a net profit of ₹36.21 lakh in the same period of FY25. The company’s revenue from operations fell significantly to ₹46.77 lakh, down from ₹256.47 lakh in Q1 FY25.

The Board of Directors approved the unaudited standalone financial results in a meeting held on August 13, 2026. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Pulindra Patel & Co., in compliance with SEBI Listing Regulations.

Financial Performance

The company’s total income for the quarter stood at ₹46.86 lakh, including other income of ₹0.09 lakh. Total expenses amounted to ₹145.74 lakh, resulting in a pre-tax loss of ₹98.88 lakh. After accounting for a tax credit of ₹0.02 lakh, the net loss after tax was ₹98.86 lakh.

What the Numbers Show

A notable divergence exists between the decline in top-line revenue and the persistence of fixed costs. While revenue from operations dropped by over 80% year-on-year, finance costs remained relatively stable at ₹17.76 lakh in Q1 FY26 versus ₹18.25 lakh in Q1 FY25. Similarly, depreciation expenses were ₹36.71 lakh, only slightly lower than the ₹38.02 lakh recorded in the prior year period. This rigidity in cost structure amplified the impact of the revenue contraction on the bottom line, turning a profitable quarter into a significant loss.

Caprolactam Chemicals returned to profitability in the financial year ended March 31, 2026, reporting a net profit of ₹176.12 lakh compared to a net loss of ₹70.87 lakh in the prior year. Revenue from operations rose 56.7% to ₹1,055.75 lakh from ₹673.96 lakh, underpinned by improved operational efficiency and market demand. For the quarter ended March 31, 2026, the company posted a net profit of ₹83.76 lakh on revenue of ₹306.70 lakh.

The Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, at a meeting held on May 30, 2026. The statutory auditors, Pulindra Patel & Co., issued an unmodified opinion on the results, confirming compliance with Indian Accounting Standards (Ind AS) and SEBI Listing Regulations. Additionally, the Board appointed M/s. Shrey Pandey & Associates as the internal auditor for the financial year 2026-27.

Total income for FY26 stood at ₹1,058.86 lakh, a significant increase from ₹674.92 lakh in the previous year. The company successfully managed its expenses, which totaled ₹842.29 lakh, up from ₹743.29 lakh in FY25, resulting in a profit before tax of ₹216.57 lakh. This marks a turnaround from the loss before tax of ₹68.37 lakh reported in the preceding year.

Financial Performance

The balance sheet reflects a strengthening of the financial position, with total assets growing to ₹1,703.96 lakh as of March 31, 2026, from ₹1,428.42 lakh a year earlier. Equity increased to ₹658.16 lakh from ₹482.87 lakh, bolstered by the retained earnings from the profitable year. Trade receivables rose to ₹621.18 lakh, indicating higher sales volumes, while borrowings stood at ₹922.90 lakh.

Cash flow from operating activities improved to a net generation of ₹164.97 lakh for FY26, compared to a net outflow of ₹56.18 lakh in the previous year. This positive operational cash flow supported investing activities, primarily the purchase of property, plant, and equipment amounting to ₹146.78 lakh. Cash and cash equivalents at the end of the year stood at ₹8.69 lakh.